Treatments for eye diseases

Israeli biotech Wize Pharma markets Israeli-developed LO2A eye drops for the treatment of ophthalmic disorders, including Dry Eye Syndrome. Wize is now to develop and trial the WP-REP1 gene therapy from Cleveland’s Copernicus for treating the rare eye disease Choroideremia.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *